Published online
doi:10.1084/jem.20070419
The Journal of Experimental Medicine, Vol. 204, No. 10, 2397-2405
The Rockefeller University Press, 0022-1007 $30.00
© Trotta et al.
The PP2A inhibitor SET regulates natural killer cell IFN-
production
Rossana Trotta1,
David Ciarlariello1,
Jessica Dal Col1,
Jeffrey Allard, II1,
Paolo Neviani1,
Ramasamy Santhanam1,
Hsiaoyin Mao1,
Brian Becknell1,2,
Jianhua Yu1,
Amy K. Ferketich3,
Brittany Thomas1,
Aalok Modi1,
Bradley W. Blaser1,2,
Danilo Perrotti1,5, and
Michael A. Caligiuri1,4,5
1 Department of Molecular Virology, Immunology and Medical Genetics, 2 Medical Scientific Program, Integrated Biomedical Graduate Program, College of Medicine and Public Health; 3 Division of Epidemiology, College of Public Health; 4 Division of Hematology and Oncology, Department of Internal Medicine; and 5 The Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210
CORRESPONDENCE Rossana Trotta: rossana.trotta{at}osumc.edu; OR Michael A. Caligiuri: michael.caligiuri{at}osumc.edu
Monokines (i.e., interleukin [IL]-12, -18, and -15) induce natural killer (NK) cells to produce interferon-
(IFN-
), which is a critical factor for immune surveillance of cancer and monocyte clearance of infection. We show that SET, which is a potent inhibitor of protein phosphatase type 2A (PP2A) activity, is highly expressed in human CD56bright NK cells, which produce more IFN-
than CD56dim NK cells. SET was up-regulated upon monokine stimulation of primary human NK cells. Furthermore, ectopic overexpression of SET significantly enhanced IFN-
gene expression in monokine-stimulated NK cells. In contrast, RNAi-mediated suppression of SET expression renders NK cells inefficient in producing high levels of IFN-
in response to monokine costimulation. Mechanistically, suppression of PP2A activity by SET is important for IFN-
gene expression in NK cells. In fact, treatment of primary human NK cells with the PP2A activator 1,9-dideoxy-forskolin, as well as administration of the drug to C57BL/6 mice, significantly reduced NK-dependent IFN-
production in response to monokine treatment. Further, SET knockdown or pharmacologic activation of PP2A diminished extracellular signal-regulated kinase 1/2, p65RelA, signal transducer and activator of transduction 4 (STAT4), and STAT5 activity in monokine-stimulated NK cells, potentially contributing to the reduction in IFN-
gene expression. Thus, SET expression is essential for suppressing PP2A phosphatase activity that would otherwise limit NK cell antitumoral and/or antiinflammatory functions by impairing NK cell production of IFN-
.
Abbreviations used: APC, allophycocyanin; CTS, cytostatin; ERK, extracellular signal-regulated kinase; I1PP2A, PP2A inhibitor 1; I2PP2A, PP2A inhibitor 2; MAP, mitogen-activated protein; MAPK, MAP kinase; PP2A, protein phosphatase type 2A; shRNA, short hairpin RNA; PP2Ac, PP2A catalytic subunit; STAT, signal transducer and activator of transduction.
M.A. Caligiuri and D. Perrotti contributed equally to this paper.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
-
Vesosky, B., Rottinghaus, E. K., Davis, C., Turner, J.
(2009). CD8 T Cells in Old Mice Contribute to the Innate Immune Response to Mycobacterium tuberculosis via Interleukin-12p70-Dependent and Antigen-Independent Production of Gamma Interferon. Infect. Immun.
77: 3355-3363
[Abstract]
[Full Text]
-
Liu, S., Liu, Z., Xie, Z., Pang, J., Yu, J., Lehmann, E., Huynh, L., Vukosavljevic, T., Takeki, M., Klisovic, R. B., Baiocchi, R. A., Blum, W., Porcu, P., Garzon, R., Byrd, J. C., Perrotti, D., Caligiuri, M. A., Chan, K. K., Wu, L.-C., Marcucci, G.
(2008). Bortezomib induces DNA hypomethylation and silenced gene transcription by interfering with Sp1/NF-{kappa}B-dependent DNA methyltransferase activity in acute myeloid leukemia. Blood
111: 2364-2373
[Abstract]
[Full Text]
-
Scott, G. B., Meade, J. L., Cook, G. P.
(2008). Profiling killers; unravelling the pathways of human natural killer cell function. Brief Funct Genomic Proteomic
0: elm037v1-elm037
[Abstract]
[Full Text]